Management of Treatment-Related Infectious Complications in High-Risk Hemato-Oncological Patients via Telemedicine

Autor: Hradská K, Popková T, Skořupová M, Mihályová J, Jelínek T, Lančová J, Schellong N, Hájek R

Publikováno v: Cancer Management and Research, Vol Volume 14, Pp 1655-1661 (2022)

Katarína Hradská,1,2 Tereza Popková,1,2 Michaela Skořupová,1,2 Jana Mihályová,2 Tomáš Jelínek,2 Jana Lančová,3 Norbert Schellong,3 Roman Hájek1,2 1Faculty of Science, University of Ostrava, Ostrava, Czech Republic; 2Departmen

Externí odkaz: https://doaj.org/article/7d57499fd8c841acb8a2c94dd1b79da4

COVID-19 in patients with chronic lymphocytic leukemia: a multicenter analysis by the Czech CLL study group.

Autor: Šimkovič M; 4th Department of Internal Medicine - Hematology, Faculty of Medicine in Hradec Králové, University Hospital and Charles University in Prague, Prague, Czech Republic. simkovicm@lfhk.cuni.cz., Turcsányi P; Department of Haematology-Oncology, University Hospital, Olomouc, Czech Republic., Špaček M; First Department of Medicine - Haematology, University General Hospital, Prague, Czech Republic., Mihályová J; Department of Hematooncology, University Hospital, Ostrava, Czech Republic., Ryznerová P; Department of Haematology-Oncology, University Hospital, Olomouc, Czech Republic., Maco M; Department of Internal Medicine - Haematology, University Hospital Královské Vinohrady, Prague, Czech Republic., Vodárek P; 4th Department of Internal Medicine - Hematology, Faculty of Medicine in Hradec Králové, University Hospital and Charles University in Prague, Prague, Czech Republic., Écsiová D; 4th Department of Internal Medicine - Hematology, Faculty of Medicine in Hradec Králové, University Hospital and Charles University in Prague, Prague, Czech Republic., Poul H; Department of Hematology and Transfusion Medicine, Hospital Pelhrimov, Pelhrimov, Czech Republic., Móciková H; Department of Internal Medicine - Haematology, University Hospital Královské Vinohrady, Prague, Czech Republic., Zuchnická J; Department of Hematooncology, University Hospital, Ostrava, Czech Republic., Panovská A; Department of Internal Medicine - Haematology and Oncology, University Hospital, Brno, Czech Republic., Lekaa M; Department of Hematology and Oncology, Medical School and Teaching Hospital in Plzen, Charles University in Prague, Plzen, Czech Republic., Oršulová M; Department of Internal Medicine - Haematology and Oncology, University Hospital, Brno, Czech Republic., Prchlíková A; Department of Internal Medicine - Haematology and Oncology, University Hospital, Brno, Czech Republic., Stejskal L; Haematology/Tranfusiology Department, Silesian Hospital Opava, Opava, Czech Republic., Mašlejová S; Department of Internal Medicine - Haematology and Oncology, University Hospital, Brno, Czech Republic., Brychtová Y; Department of Internal Medicine - Haematology and Oncology, University Hospital, Brno, Czech Republic., Bezděková L; Department of Internal Medicine - Haematology and Oncology, University Hospital, Brno, Czech Republic., Papajík T; Department of Haematology-Oncology, University Hospital, Olomouc, Czech Republic., Lysák D; Department of Hematology and Oncology, Medical School and Teaching Hospital in Plzen, Charles University in Prague, Plzen, Czech Republic., Trněný M; First Department of Medicine - Haematology, University General Hospital, Prague, Czech Republic., Smolej L; 4th Department of Internal Medicine - Hematology, Faculty of Medicine in Hradec Králové, University Hospital and Charles University in Prague, Prague, Czech Republic., Doubek M; Department of Internal Medicine - Haematology and Oncology, University Hospital, Brno, Czech Republic.

Publikováno v: Annals of hematology [Ann Hematol] 2023 Apr; Vol. 102 (4), pp. 811-817. Date of Electronic Publication: 2023 Feb 27.

External validation of International Prognostic Score for asymptomatic early stage chronic lymphocytic leukaemia and proposal of an alternative score.

Autor: Smolej L; 4th Department of Internal Medicine - Haematology, University Hospital and Faculty of Medicine, Hradec Králové, Czech Republic., Turcsányi P; Department of Haematology-Oncology, University Hospital, Olomouc, Czech Republic., Kubová Z; Department of Haematology-Oncology, University Hospital, Olomouc, Czech Republic., Zuchnická J; Department of Haematooncology, University Hospital Ostrava and Faculty of Medicine, Ostrava University, Ostrava, Czech Republic., Mihályová J; Department of Haematooncology, University Hospital Ostrava and Faculty of Medicine, Ostrava University, Ostrava, Czech Republic., Šimkovič M; 4th Department of Internal Medicine - Haematology, University Hospital and Faculty of Medicine, Hradec Králové, Czech Republic., Vodárek P; 4th Department of Internal Medicine - Haematology, University Hospital and Faculty of Medicine, Hradec Králové, Czech Republic., Krčméryová M; Department of Internal Medicine - Haematology, University Hospital Královské Vinohrady, Prague, Czech Republic., Móciková H; Department of Internal Medicine - Haematology, University Hospital Královské Vinohrady, Prague, Czech Republic., Brejcha M; Department of Haematology, Oncology Center, Nový Jičín, Czech Republic, Prague, Czech Republic., Špaček M; First Department of Medicine - Haematology, University General Hospital, Prague, Czech Republic.

Publikováno v: British journal of haematology [Br J Haematol] 2021 Apr; Vol. 193 (1), pp. 133-137. Date of Electronic Publication: 2020 Sep 10.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

CD38 targeted treatment for multiple myeloma.

Autor: Jelínek T, Mihályová J, Hájek R

Publikováno v: Vnitrni lekarstvi [Vnitr Lek] Fall 2018; Vol. 64 (10), pp. 939-948.